Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-23

Clinical Trial Update: Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluating clozapine for reducing violence in people with schizophrenia or schizoaffective disorder; the study is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOZARIL (Clozapine)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: RECRUITING